David G. May

425 total citations
16 papers, 325 citations indexed

About

David G. May is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, David G. May has authored 16 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in David G. May's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). David G. May is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). David G. May collaborates with scholars based in United States and United Kingdom. David G. May's co-authors include Robert A. Branch, James A. Porter, G. Wilkinson, Jack Uetrecht, James M. Fujimoto, Peter B. Corr, I. M. Weiner, Charles E. Inturrisi, Mary Ellen Csuka and S. Bobo Tanner and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

David G. May

16 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David G. May United States	10	105	72	55	54	53	16	325
K. Frislid Norway	14	66 0.6×	68 0.9×	63 1.1×	96 1.8×	32 0.6×	22	516
J. Moppert Switzerland	11	77 0.7×	59 0.8×	134 2.4×	76 1.4×	39 0.7×	25	472
Raymond Miller South Africa	9	49 0.5×	38 0.5×	36 0.7×	54 1.0×	58 1.1×	20	350
Berry J. Kline United States	10	86 0.8×	67 0.9×	90 1.6×	116 2.1×	56 1.1×	17	376
Evelyn Jones United States	10	97 0.9×	32 0.4×	55 1.0×	47 0.9×	53 1.0×	10	418
Michael N. Hartnett United States	7	60 0.6×	76 1.1×	151 2.7×	114 2.1×	37 0.7×	9	453
Julie A. Johnson United States	9	89 0.8×	46 0.6×	28 0.5×	60 1.1×	38 0.7×	9	305
Tatsuji Iga Japan	9	89 0.8×	70 1.0×	41 0.7×	129 2.4×	43 0.8×	17	359
W. F. Banks United States	9	71 0.7×	41 0.6×	85 1.5×	64 1.2×	17 0.3×	14	356
U. C. Dubach Switzerland	12	50 0.5×	37 0.5×	50 0.9×	82 1.5×	31 0.6×	24	295

Countries citing papers authored by David G. May

Since Specialization

Citations

This map shows the geographic impact of David G. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. May more than expected).

Fields of papers citing papers by David G. May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. May. The network helps show where David G. May may publish in the future.

Co-authorship network of co-authors of David G. May

This figure shows the co-authorship network connecting the top 25 collaborators of David G. May. A scholar is included among the top collaborators of David G. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. May. David G. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

May, David G., et al.. (2020). Treatment of double depression: A meta-analysis. Psychiatry Research. 291. 113262–113262. 2 indexed citations

Berlin, Cheston M., et al.. (1995). Reappraisal of lytic cocktail/demerol, phenergan, and thorazine (DPT) for the sedation of children. 95(4). 598–601. 29 indexed citations

May, David G.. (1994). Genetic Differences in Drug Disposition. The Journal of Clinical Pharmacology. 34(9). 881–897. 45 indexed citations

May, David G., Rebecca Naukam, J. R. Kambam, & Robert A. Branch. (1992). Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 1057–1061. 16 indexed citations

May, David G., et al.. (1992). The disposition of dapsone in cirrhosis. Clinical Pharmacology & Therapeutics. 51(6). 689–700. 35 indexed citations

May, David G., Carol M. Black, Nancy J. Olsen, et al.. (1990). Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin. Clinical Pharmacology & Therapeutics. 48(3). 286–295. 45 indexed citations

May, David G., James A. Porter, Jack Uetrecht, G. Wilkinson, & Robert A. Branch. (1990). The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects. Clinical Pharmacology & Therapeutics. 48(6). 619–627. 60 indexed citations

Ward, Stephen A., David G. May, Andrew Heath, & Robert A. Branch. (1988). Carbaryl Metabolism is Inhibited by Ctmetidine in the Isolated Perfused Rat Liver and in Man. Journal of Toxicology Clinical Toxicology. 26(5-6). 269–281. 8 indexed citations

May, David G., et al.. (1987). Vancomycin entry into lung lymph in sheep. Antimicrobial Agents and Chemotherapy. 31(11). 1689–1691. 7 indexed citations

10.

Hudnall, S. David, et al.. (1979). Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice.. PubMed. 14(4). 587–94. 7 indexed citations

11.

Corr, Peter B. & David G. May. (1975). Renal mechanisms for the excretion of nicotinic acid.. Journal of Pharmacology and Experimental Therapeutics. 192(1). 195–200. 15 indexed citations

12.

Blanchard, Kenneth C., et al.. (1972). URICOSURIC POTENCY OF 2-SUBSTITUTED ANALOGS OF PROBENECID. Journal of Pharmacology and Experimental Therapeutics. 180(2). 397–410. 11 indexed citations

13.

May, David G. & I. M. Weiner. (1971). THE RENAL MECHANISMS FOR THE EXCRETION OF m-HYDROXYBENZOIC ACID IN CEBUS MONKEYS: RELATIONSHIP TO URATE TRANSPORT. Journal of Pharmacology and Experimental Therapeutics. 176(2). 407–417. 9 indexed citations

14.

May, David G., et al.. (1970). MECHANISM OF THE RENAL TUBULAR TRANSPORT OF MORPHINE AND MORPHINE ETHEREAL SULFATE IN THE CHICKEN. Journal of Pharmacology and Experimental Therapeutics. 172(2). 224–229. 15 indexed citations

15.

Inturrisi, Charles E., David G. May, & James M. Fujimoto. (1968). The diuretic effect of morphine in the chicken. European Journal of Pharmacology. 5(1). 79–84. 4 indexed citations

16.

May, David G., James M. Fujimoto, & Charles E. Inturrisi. (1967). THE TUBULAR TRANSPORT AND METABOLISM OF MORPHINE-N-METHYL-C14 BY THE CHICKEN KIDNEY. Journal of Pharmacology and Experimental Therapeutics. 157(3). 626–635. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact